Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome

Thomas M. Kaffenberger; Rajarsi Mandal; Barry M. Schaitkin; Barry E. Hirsch

doi:10.1002/lary.26191

Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome

Thomas M. Kaffenberger, Rajarsi Mandal, Barry M. Schaitkin, Barry E. Hirsch

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Objective tinnitus associated with eyelid closure is a rare clinical entity with only a few reported cases. This association previously was identified as forced eyelid closure syndrome (FECS) and involves an aberrant neural reflex between cranial nerve VII (activating the orbicularis oculi muscle) and cranial nerve V (activating the tensor tympani muscle). We present a 52-year-old Caucasian female with a 2-month history of FECS who was successfully treated with intrapalatal botulinum toxin, with full resolution of her objective tinnitus symptoms. This is the first reported use of botulinum toxin in FECS. Laryngoscope, 127:1199–1201, 2017.

Original language	English (US)
Pages (from-to)	1199-1201
Number of pages	3
Journal	Laryngoscope
Volume	127
Issue number	5
DOIs	https://doi.org/10.1002/lary.26191
State	Published - May 1 2017
Externally published	Yes

Keywords

botulinum toxin
FECS
objective tinnitus
palatal tinnitus

ASJC Scopus subject areas

Otorhinolaryngology

Access to Document

10.1002/lary.26191

Cite this

@article{9f44fbdac492409e8c5582d4813d93f7,

title = "Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome",

abstract = "Objective tinnitus associated with eyelid closure is a rare clinical entity with only a few reported cases. This association previously was identified as forced eyelid closure syndrome (FECS) and involves an aberrant neural reflex between cranial nerve VII (activating the orbicularis oculi muscle) and cranial nerve V (activating the tensor tympani muscle). We present a 52-year-old Caucasian female with a 2-month history of FECS who was successfully treated with intrapalatal botulinum toxin, with full resolution of her objective tinnitus symptoms. This is the first reported use of botulinum toxin in FECS. Laryngoscope, 127:1199–1201, 2017.",

keywords = "botulinum toxin, FECS, objective tinnitus, palatal tinnitus",

author = "Kaffenberger, {Thomas M.} and Rajarsi Mandal and Schaitkin, {Barry M.} and Hirsch, {Barry E.}",

year = "2017",

month = may,

day = "1",

doi = "10.1002/lary.26191",

language = "English (US)",

volume = "127",

pages = "1199--1201",

journal = "Laryngoscope",

issn = "0023-852X",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome

AU - Kaffenberger, Thomas M.

AU - Mandal, Rajarsi

AU - Schaitkin, Barry M.

AU - Hirsch, Barry E.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Objective tinnitus associated with eyelid closure is a rare clinical entity with only a few reported cases. This association previously was identified as forced eyelid closure syndrome (FECS) and involves an aberrant neural reflex between cranial nerve VII (activating the orbicularis oculi muscle) and cranial nerve V (activating the tensor tympani muscle). We present a 52-year-old Caucasian female with a 2-month history of FECS who was successfully treated with intrapalatal botulinum toxin, with full resolution of her objective tinnitus symptoms. This is the first reported use of botulinum toxin in FECS. Laryngoscope, 127:1199–1201, 2017.

AB - Objective tinnitus associated with eyelid closure is a rare clinical entity with only a few reported cases. This association previously was identified as forced eyelid closure syndrome (FECS) and involves an aberrant neural reflex between cranial nerve VII (activating the orbicularis oculi muscle) and cranial nerve V (activating the tensor tympani muscle). We present a 52-year-old Caucasian female with a 2-month history of FECS who was successfully treated with intrapalatal botulinum toxin, with full resolution of her objective tinnitus symptoms. This is the first reported use of botulinum toxin in FECS. Laryngoscope, 127:1199–1201, 2017.

KW - botulinum toxin

KW - FECS

KW - objective tinnitus

KW - palatal tinnitus

UR - http://www.scopus.com/inward/record.url?scp=84992455333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992455333&partnerID=8YFLogxK

U2 - 10.1002/lary.26191

DO - 10.1002/lary.26191

M3 - Article

C2 - 27717035

AN - SCOPUS:84992455333

SN - 0023-852X

VL - 127

SP - 1199

EP - 1201

JO - Laryngoscope

JF - Laryngoscope

IS - 5

ER -

Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this